I did a little bit of research and for people in the UK it appears to be substantially less. I found a few health companies offering it for <$250/mo. I’ll probably wait until it’s readily available on the NHS but it is tempting.
I'm supposed to book a follow up appointment after I've read about it, so I guess I'll find out what he means then.
For trirzepatide: https://www.mounjaro.com/hcp/savings-resources
They typically are income blind and make your out-of-pocket price negligible. I'm on a med (Skyrizi) that's $18k per shot, one every three months; their assistance program ensures I don't pay more than $5.
They chip in on the deductible/coinsurance/copay, you don't skip the medication due to cost, and they still get significant money out of your insurer. Everybody wins, until everyone's premiums go up next year.
Individual consumers pay basically nothing and companies are still incentivized to innovate and create new medicines
They pay via premiums - mine went up to $2,792/month this year - or if their employer pays those, via the resulting wage impact.
And, as a result, we spend 2-3x what the rest of the OECD spends on healthcare - public and private spending - with roughly the same health outcomes.
Look at 1800rxonline.
It's a case of either paying for a private prescription now, or waiting until it's made more accessible on the NHS.